GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Price-to-Owner-Earnings

China Isotope & Radiation (HKSE:01763) Price-to-Owner-Earnings : (As of May. 23, 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Price-to-Owner-Earnings?

As of today (2024-05-23), China Isotope & Radiation's share price is HK$11.16. China Isotope & Radiation does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for China Isotope & Radiation's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of China Isotope & Radiation was 58.72. The lowest was 12.89. And the median was 27.49.


HKSE:01763's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.285
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-23), China Isotope & Radiation's share price is HK$11.16. China Isotope & Radiation's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.27. Therefore, China Isotope & Radiation's PE Ratio for today is 8.79.

As of today (2024-05-23), China Isotope & Radiation's share price is HK$11.16. China Isotope & Radiation's EPS without NRI for the trailing twelve months (TTM) ended in was HK$1.01. Therefore, China Isotope & Radiation's PE Ratio without NRI for today is 11.06.

During the past 9 years, China Isotope & Radiation's highest PE Ratio without NRI was 36.85. The lowest was 8.29. And the median was 14.73.


China Isotope & Radiation Price-to-Owner-Earnings Historical Data

The historical data trend for China Isotope & Radiation's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Price-to-Owner-Earnings Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only 38.62 - 22.87 - -

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.87 - - - -

Competitive Comparison of China Isotope & Radiation's Price-to-Owner-Earnings

For the Medical Devices subindustry, China Isotope & Radiation's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Price-to-Owner-Earnings falls into.



China Isotope & Radiation Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

China Isotope & Radiation's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=11.16/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation  (HKSE:01763) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


China Isotope & Radiation Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines